Ensign Group (ENSG) fundamentals: P/E, valuation, undervalued?
Ensign Group · Health Care · ref. ETF XLV · price $173.54
In short — Ensign Group trades at 28.4× earnings (P/E), 20.3× forward, with a net margin of 6.9 % and revenue growth of +17 %. Read: Fairly valued (P/E 20 in line with ~17% growth (PEG 1.2)).
Is Ensign Group stock cheap or undervalued? A good time to buy? Here are its fundamentals — P/E, PEG, margin and income statement — to judge its valuation.
📈 1-year price
$173.54+0.5% over range
Aug 28, 25low $147.13 · high $215.83Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
0% recommend buying · 1 analysts
Valuation : Fairly valued — P/E 20 in line with ~17% growth (PEG 1.2)
Valuation
28.4
P/E (price/earnings)
20.3
Forward P/E
1.70
PEG
4.1
Price/book (P/B)
$10.1B
Market cap
6.12
EPS
Profitability & growth
6.9 %
Net margin
+17 %
Revenue growth
+17 %
Earnings growth
$2.3B
Total debt
Ensign Group income statement
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| 2022 | $3.0B | $225M | 7.4 % |
| 2023 | $3.7B | $209M | 5.6 % |
| 2024 | $4.3B | $298M | 7.0 % |
| 2025 | $5.1B | $344M | 6.8 % |
⚠️ Indicative financial data (Yahoo Finance), not investment advice. Amounts in $.
Frequently asked questions
What is Ensign Group's P/E and is the stock undervalued? What's a good P/E?
Ensign Group's P/E is 28.4 (forward 20.3). Below ~15 = fairly cheap, above ~30 = expensive. Our valuation verdict: "Fairly valued".
Is Ensign Group profitable?
Ensign Group has a net margin of 6.9 % (EPS 6.12). The company is profitable.
Is ENSG stock expensive?
Our read: "Fairly valued" — P/E 20 in line with ~17% growth (PEG 1.2). Cross-check with growth and sector.
💬 A question about Ensign Group? The JPI assistant answers using our backtest data.
Keep exploring Ensign Group